Patients randomized to alteplase in addition to standard care had a significantly higher mortality rate during the first 7 days after treatment, but a significantly lower risk of death between 8 days and 3 years after treatment.

ACP Hospitalist provides news and information for hospitalists, covering the major issues in the field. All published material, which is covered by copyright, represents the views of the contributor and does not reflect the opinion of the American College of Physicians or any other institution unless clearly stated.